Skip to main content
TipRanks
Go Ultimate75% OFF

Lexicon Pharmaceuticals (LXRX) Drug Pipeline

1,836 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
SotagliflozinObstructive Cardiomyopathy, Hypertrophic, Non-Obstructive Hypertrophic CardiomyopathyPhase IIIRecruitingA Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyJun 25, 2024―
Lx9211 (Blinded)Diabetic Peripheral Neuropathic PainPhase IICompletedA Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)Nov 30, 2023―
Lx9211Postherpetic NeuralgiaPhase IICompletedEfficacy and Safety of LX9211 in Participants With Postherpetic NeuralgiaDec 04, 2020―
Lx9211Diabetes, Diabetic Peripheral NeuropathyPhase IICompletedEfficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic PainJun 29, 2020―
SotagliflozinType 2 Diabetes Mellitus, Heart FailurePhase IIITerminatedEffect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)Apr 30, 2018―
SotagliflozinType 2 Diabetes MellitusPhase IIITerminatedEfficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic ControlDec 21, 2017―
Sotagliflozin, EmpagliflozinType 2 Diabetes MellitusPhase IIICompletedEfficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With MetforminNov 20, 2017―
Metformin, Glimepiride, Sotagliflozin (Sar439954)Type 2 Diabetes MellitusPhase IIICompletedEfficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin MonotherapyNov 02, 2017―
Telotristat EthylHepatic ImpairmentPhase ICompletedStudy to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic ImpairmentOct 24, 2017―
SotagliflozinType 2 Diabetes Mellitus, Heart Failure, Chronic Kidney DiseasesPhase IIITerminatedEffect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskOct 16, 2017―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lexicon Pharmaceuticals (LXRX) have in its pipeline
Lexicon Pharmaceuticals LXRX is currently developing the following drugs: Sotagliflozin, Lx9211 (Blinded), Lx9211, Sotagliflozin, Empagliflozin, Metformin, Glimepiride, Sotagliflozin (Sar439954), Telotristat Ethyl, Omeprazole 40 Mg, Famotidine 40 Mg, Telotristat Ethyl 250 Mg, Sotagliflozin, Insulin Glargine (Hoe901), Oral Antidiabetes Drugs (Oads), Metformin, Sulfonylurea, Sotagliflozin (Sar439954), Metformin, Sotagliflozin (Sar439954), Sotagliflozin (Sar439954), Sotagliflozin, Oral Contraceptive, Oral Contraceptive + Sotagliflozin, Lx4211, Telotristat Etiprate, Octreotide Acetate, Telotristat Etiprate, Telotristat Etiprate, Octreotide Lar Depot. These drug candidates are in various stages of clinical development as the company works toward FDA approval.